Webinar: Japan’s Regulatory Requirements for Cell and Gene Therapy

On the latest C-Cast mini-webinar by CMIC, Dr. Kazuhiro Fukuta, Senior Consultant and the Head of Regenerative Medicine Group in CMIC, discusses the complexities of the regulatory framework for cell and gene therapy in Japan. In addition, Dr. Fukuta breaks down the initial steps of the regulatory process in Japan in a straightforward manner. Finally, he gives helpful tips for successful clinical development in the Japanese life sciences industry.

According to CMIC, Dr. Fukuta, “is specialized in science, regulation and clinical development of regenerative medicine, including cell and gene therapies, based on his experiences as a researcher of biochemistry, molecular biology and molecular regenerative medicine at university and his 10 years’ career at a biotech company. He is currently consulting with various Japanese and overseas companies to develop cell and gene therapy products in Japan.”

Sign up for the free mini-webinar by clicking here.

(Source: CMIC, December 14^th, 2021)